10hon MSN
Grok AI obscene content row: X sends detailed reply, Indian govt isn't satisfied; Here's why
X provided a lengthy and detailed response, stating that it respects Indian laws and adheres to stipulated guidelines. It ...
Zenas BioPharma, Inc. (“Zenas,” “Zenas BioPharma” or the “Company”) (Nasdaq: ZBIO), a clinical-stage global biopharmaceutical company committed to being a leader in the development and ...
A shop has been ordered to close until March next year and forced to pay costs of more than £12k after illegal vapes, tobacco ...
A new experimental vaccine for nipah virus has successfully completed its first human trial. The vaccine was well-tolerated by healthy adults and stimulated an immune response. This marks a ...
Irish fishing vessel owners challenge the government’s trawling ban, citing economic impact and loss of historical fishing ...
FibroBiologics is pursuing a development program for CYPS317 with the goal of advancing first-in-human clinical trials following FDA review of the IND filing. The IND submission includes comprehensive ...
PRESS RELEASE AB SCIENCE REPORTS FOURTH CONSECUTIVE CASE OF RESPONSE FROM PHASE 1 DATA FOR THE COMBINATION OF AB8939 WITH VENETOCLAX FOR THE TREATMENT OF REFRACTORY OR RELAPSED ACUTE MYELOID LEUKEMIA ...
Introduction Each year, millions of people experience recurrent diverticulitis episodes. Elective sigmoid colon resection reduces the risk of recurrence, but The American Society of Colon and Rectal ...
There are no established treatment options for patients with meningioma recurring after surgery and radiotherapy.
Exploring clinical development plan options including a controlled human infection model (CHIM) and a Phase 2/3 adaptive field studyExpect to ...
Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (“Tonix” or the “Company”), a fully-integrated commercial stage biotechnology company, today announced it has entered into a securities purchase ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results